Caleres Inc CAL
We take great care to ensure that the data presented and summarized in this overview for CALERES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CAL
View all-
Black Rock Inc. New York, NY5.41MShares$161 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$94.4 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.17MShares$64.6 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.88MShares$56 Million0.02% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.84MShares$54.6 Million0.04% of portfolio
-
State Street Corp Boston, MA1.52MShares$45.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.51MShares$44.8 Million0.12% of portfolio
-
American Century Companies Inc Kansas City, MO1.04MShares$31 Million0.02% of portfolio
-
Neuberger Berman Group LLC New York, NY899KShares$26.7 Million0.02% of portfolio
-
First Manhattan CO New York, NY821KShares$24.4 Million0.08% of portfolio
Latest Institutional Activity in CAL
Top Purchases
Top Sells
About CAL
Caleres, Inc. engages in the retail and wholesale of footwear in the United States, Canada, China, and Guam. It operates through Famous Footwear and Brand Portfolio segments. The company offers licensed, branded, and private-label athletic, casual, and dress footwear products to women, men, and children. Its retail shoe stores provide brand name athletic, casual, and dress shoes, including Nike, Skechers, adidas, Vans, Converse, Crocs, Puma, Birkenstock, New Balance, Asics, New Balance, Under Armour, Bearpaw, Timberland, Sperry, and Dr. Martens, as well as company-owned and licensed brands, such as Dr. Scholl's Shoes, Blowfish Malibu, LifeStride, Naturalizer, Zodiac, Circus by Sam Edelman, Franco Sarto, and Ryka. The company also operates naturalizer.com, naturalizer.ca, vionicshoes.com, samedelman.com, allenedmonds.com, drschollsshoes.com, lifestride.com, francosarto.com, ryka.com, bzees.com, and zodiacshoes.com, as well as Vince.com, blowfishshoes.com, and veronicabeard.com websites. In addition, it designs, sources, manufactures, and markets footwear to retail stores, such as national chains, online retailers, department stores, mass merchandisers, independent retailers, and catalogs. Further, the company wholesales men's apparel, leather goods, and accessories under the Allen Edmonds brand; footwear for women under LifeStride brand; Italian footwear Franco Sarto brand; athletic footwear for women under the Rykä brand; women's shoe collection under the Vince brand; and women's footwear under the Bzees brand; other footwear under Zodiac brand; and women's footwear collection under Veronica Beard brand, as well as Via Spiga brand. It operates approximately 980 retail stores. The company was formerly known as Brown Shoe Company, Inc. Caleres, Inc. was founded in 1878 and is headquartered in St. Louis, Missouri.
Insider Transactions at CAL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 12
2024
|
Jack Calandra SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,676
-9.21%
|
$144,956
$31.12 P/Share
|
Jul 22
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
17,068
-10.19%
|
$597,380
$35.45 P/Share
|
Jul 15
2024
|
Carla C Hendra Director |
SELL
Open market or private sale
|
Direct |
5,349
-100.0%
|
$176,517
$33.07 P/Share
|
Jun 18
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
6,299
-3.62%
|
$207,867
$33.78 P/Share
|
Jun 17
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
19,764
-10.21%
|
$652,212
$33.66 P/Share
|
Jun 03
2024
|
Mahendra R Gupta Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,564
+14.46%
|
$159,740
$35.06 P/Share
|
Jun 03
2024
|
Ward M Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,564
+5.1%
|
$159,740
$35.06 P/Share
|
Jun 03
2024
|
Bruce K Thorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,564
+27.03%
|
$159,740
$35.06 P/Share
|
May 31
2024
|
Wenda Harris Millard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,349
+13.46%
|
-
|
May 26
2024
|
Carla C Hendra Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,348
+50.0%
|
-
|
May 23
2024
|
Diane M Sullivan Executive Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
14,739
-7.08%
|
$515,865
$35.98 P/Share
|
May 22
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
12,584
-5.7%
|
$453,024
$36.07 P/Share
|
May 21
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
11,994
-2.59%
|
$431,784
$36.42 P/Share
|
May 20
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
21,771
-4.37%
|
$783,756
$36.55 P/Share
|
May 06
2024
|
John W Schmidt President & CEO, Caleres |
SELL
Open market or private sale
|
Direct |
25,332
-3.45%
|
$937,284
$37.63 P/Share
|
Apr 24
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
6,856
-2.62%
|
$253,672
$37.09 P/Share
|
Apr 23
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
24,499
-4.3%
|
$906,463
$37.02 P/Share
|
Apr 22
2024
|
Diane M Sullivan Executive Chair |
SELL
Open market or private sale
|
Direct |
12,126
-4.07%
|
$424,410
$35.99 P/Share
|
Apr 08
2024
|
Daniel R Freidman Chief Sourcing Officer |
SELL
Open market or private sale
|
Direct |
15,000
-18.95%
|
$555,000
$37.0 P/Share
|
Mar 25
2024
|
Mark A Schmitt SVP, Chief Logistics Officer |
SELL
Open market or private sale
|
Direct |
18,373
-26.54%
|
$753,293
$41.01 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 114K shares |
---|---|
Exercise of conversion of derivative security | 10.7K shares |
Payment of exercise price or tax liability | 181K shares |
---|---|
Open market or private sale | 473K shares |
Bona fide gift | 10K shares |